AAAAAA

   
Results: 1-10 |
Results: 10
A PHASE-I STUDY OF INTERLEUKIN-6 AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH POOR-PROGNOSIS HODGKINS-DISEASE
Authors: IMRIE KR SHERIDAN B COLWILL R CRUMP M STEWART AK MCCRAE J DANISH R SUTTON D ROMEYER F KEATING A
Citation: Kr. Imrie et al., A PHASE-I STUDY OF INTERLEUKIN-6 AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH POOR-PROGNOSIS HODGKINS-DISEASE, Leukemia & lymphoma, 25(5-6), 1997, pp. 555-563
ABNORMAL THYROID-STIMULATING HORMONE (TSH) LEVELS IN ADULTS FOLLOWINGALLOGENEIC BONE-MARROW TRANSPLANTS
Authors: ALFIAR FZ COLWILL R LIPTON JH FYLES G SPANER D MESSNER H
Citation: Fz. Alfiar et al., ABNORMAL THYROID-STIMULATING HORMONE (TSH) LEVELS IN ADULTS FOLLOWINGALLOGENEIC BONE-MARROW TRANSPLANTS, Bone marrow transplantation, 19(10), 1997, pp. 1019-1022
THE ROLE OF INTENSIVE THERAPY AND AUTOLOGOUS BLOOD AND MARROW TRANSPLANTATION FOR CHEMOTHERAPY-SENSITIVE RELAPSED AND PRIMARY REFRACTORY NON-HODGKINS-LYMPHOMA - IDENTIFICATION OF MAJOR PROGNOSTIC GROUPS
Authors: PRINCE HM IMRIE K CRUMP M STEWART AK GIROUARD C COLWILL R BRANDWEIN J TSANG RW SCOTT JG SUTTON DMC PANTALONY D CARSTAIRS K SUTCLIFFE SB KEATING A
Citation: Hm. Prince et al., THE ROLE OF INTENSIVE THERAPY AND AUTOLOGOUS BLOOD AND MARROW TRANSPLANTATION FOR CHEMOTHERAPY-SENSITIVE RELAPSED AND PRIMARY REFRACTORY NON-HODGKINS-LYMPHOMA - IDENTIFICATION OF MAJOR PROGNOSTIC GROUPS, British Journal of Haematology, 92(4), 1996, pp. 880-889
MINI-BEAM AS SALVAGE THERAPY FOR RELAPSED OR REFRACTORY HODGKINS-DISEASE BEFORE INTENSIVE THERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION
Authors: COLWILL R CRUMP M COUTURE F DANISH R STEWART AK SUTTON DMC SCOTT JG SUTCLIFFE SB BRANDWEIN JM KEATING A
Citation: R. Colwill et al., MINI-BEAM AS SALVAGE THERAPY FOR RELAPSED OR REFRACTORY HODGKINS-DISEASE BEFORE INTENSIVE THERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Journal of clinical oncology, 13(2), 1995, pp. 396-402
PHASE-I STUDY OF INTERLEUKIN-6 (IL-6) AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR PATIENTS WITH POOR-PROGNOSIS HODGKINS-DISEASE
Authors: IMRIE K COLWILL R CRUMP M STEWART AK SUTTON DMC SCOTT JG MCCRAE J ROMEYER F KEATING A AMATO D
Citation: K. Imrie et al., PHASE-I STUDY OF INTERLEUKIN-6 (IL-6) AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR PATIENTS WITH POOR-PROGNOSIS HODGKINS-DISEASE, Experimental hematology, 22(8), 1994, pp. 780-780
IMMUNE RECONSTITUTION AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT)
Authors: IMRIE K COLWILL R STEWART AK CRUMP M NISBETBROWN E CARSTAIRS K KEATING A LIPTON J
Citation: K. Imrie et al., IMMUNE RECONSTITUTION AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT), Experimental hematology, 22(8), 1994, pp. 782-782
REMISSION STATUS AT TRANSPLANT - A POWERFUL PREDICTOR OF OUTCOME AFTER AUTOTRANSPLANT FOR INTERMEDIATE GRADE NHL
Authors: PRINCE HM IMRIE K COLWILL R CRUMP M STEWART AK BRANDWEIN JM SUTCLIFFE SB KEATING A
Citation: Hm. Prince et al., REMISSION STATUS AT TRANSPLANT - A POWERFUL PREDICTOR OF OUTCOME AFTER AUTOTRANSPLANT FOR INTERMEDIATE GRADE NHL, Blood, 84(10), 1994, pp. 10000719-10000719
ESCALATING THE MELPHALAN DOSE IN A REGIMEN INCLUDING HIGH-DOSE ETOPOSIDE FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IS NOT ASSOCIATED WITH ENHANCED TOXICITY
Authors: SHER GD COLWILL R COUTURE F STEWART K CRUMP M KEATING A
Citation: Gd. Sher et al., ESCALATING THE MELPHALAN DOSE IN A REGIMEN INCLUDING HIGH-DOSE ETOPOSIDE FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IS NOT ASSOCIATED WITH ENHANCED TOXICITY, Experimental hematology, 21(8), 1993, pp. 1130-1130
ACCURATE ENUMERATION OF CD34-MARROW AND PERIPHERAL-BLOOD OF PATIENTS AFTER CHEMOTHERAPY AND GM-CSF( CELLS IN BONE)
Authors: SUTHERLAND DR ANANIA S NAYAR R COLWILL R STEWART K SUTTON D KEATING A
Citation: Dr. Sutherland et al., ACCURATE ENUMERATION OF CD34-MARROW AND PERIPHERAL-BLOOD OF PATIENTS AFTER CHEMOTHERAPY AND GM-CSF( CELLS IN BONE), Experimental hematology, 21(8), 1993, pp. 1163-1163
PHASE-I TRIAL OF INTERLEUKIN-6 (IL-6) AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR PATIENTS WITH POOR-PROGNOSIS HODGKINS-DISEASE
Authors: COLWILL R CRUMP M STEWART AK DANISH R SUTTON DMC SCOTT JG ROMEYER F KEATING A
Citation: R. Colwill et al., PHASE-I TRIAL OF INTERLEUKIN-6 (IL-6) AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR PATIENTS WITH POOR-PROGNOSIS HODGKINS-DISEASE, Blood, 82(10), 1993, pp. 10000646-10000646
Risultati: 1-10 |